Invention Grant
US07648979B2 5-amido-(1H-indol-2-yl)-piperazin-1-yl-methanone derivatives
失效
5-（1H-吲哚-2-基） - 哌嗪-1-基 - 甲酮衍生物
- Patent Title: 5-amido-(1H-indol-2-yl)-piperazin-1-yl-methanone derivatives
- Patent Title (中): 5-（1H-吲哚-2-基） - 哌嗪-1-基 - 甲酮衍生物
-
Application No.: US12020637Application Date: 2008-01-28
-
Publication No.: US07648979B2Publication Date: 2010-01-19
- Inventor: Matthias Nettekoven , Jean-Marc Plancher , Hans Richter , Olivier Roche , Sven Taylor
- Applicant: Matthias Nettekoven , Jean-Marc Plancher , Hans Richter , Olivier Roche , Sven Taylor
- Applicant Address: US NJ Nutley
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Nutley
- Agent George W. Johnston; Dennis P. Tramaloni; Brian C. Remy
- Priority: EP07101883 20070207
- Main IPC: A61K31/404
- IPC: A61K31/404 ; A61P3/04 ; C07D401/04 ; C07D209/42
Abstract:
The present invention relates to compounds of formula I wherein A, G and R1 to R3 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
Public/Granted literature
- US20080188487A1 5-AMIDO-(1H-INDOL-2-YL)-PIPERAZIN-1-YL-METHANONE DERIVATIVES Public/Granted day:2008-08-07
Information query
IPC分类:
